MARY LOUISE RAY: Open Payments
NPI 1669804258 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,598 in 87 payments from 13 companies in 2025. Trend: 2023 $18 · 2024 $513 · 2025 $1,598
Food & beverage: $1,594Education: $4
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $366 |
| Otsuka America Pharmaceutical, Inc. | 15 | $248 |
| Alkermes, Inc. | 8 | $202 |
| Vanda Pharmaceuticals Inc. | 5 | $161 |
| Supernus Pharmaceuticals, Inc. | 15 | $138 |
| Axsome Therapeutics, Inc. | 5 | $98 |
| Corium, LLC | 6 | $93 |
| ABBVIE INC. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| Tris Pharma Inc | 3 | $61 |
Products named: CAPLYTA, REXULTI, ARISTADA, FANAPT, Qelbree, Azstarys, Auvelity, VRAYLAR.
Industry payments across FL — which companies pay providers there.
